MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with R

Roflumilast

Roflumilast 250microgram tablets

Compatible

Stability notes for Roflumilast 250microgram tablets

This medicinal product does not require any special storage conditions.

Provenance

This compatibility recommendation is derived from Daxas 250microgram tablets (AstraZeneca UK Ltd).

Suppliers

Daxas 250microgram tablets (AstraZeneca UK Ltd)
Roflumilast 250microgram tablets (Alliance Healthcare (Distribution) Ltd)
Roflumilast 250microgram tablets (Torrent Pharma (UK) Ltd)

Roflumilast 500microgram tablets

Compatible

Stability notes for Roflumilast 500microgram tablets

This medicinal product does not require any special storage conditions.

Provenance

This compatibility recommendation is derived from Daxas 500microgram tablets (AstraZeneca UK Ltd).

Suppliers (4) of Roflumilast 500microgram tablets
Daxas 500microgram tablets (AstraZeneca UK Ltd)
Roflumilast 500microgram tablets (Alliance Healthcare (Distribution) Ltd)
Roflumilast 500microgram tablets (Milpharm Ltd)
Roflumilast 500microgram tablets (Torrent Pharma (UK) Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.